The use of “positron emission tomography (PET)”, “prostate-specific membrane antigen (PSMA)”, “androgen deprivation therapy”, “biochemical recurrence”, “radical prostatectomy”, and “lymph node metastases” within this cluster highlights the specific challenges and opportunities within this area of research. The gene discussed is FOLH1; the disease is metastatic malignant neoplasm in the lymph nodes.